The CDMO Capacity Race Has Changed
18 August 2026.CDMO competition shifts toward specialist capacity, geography and selective outsourcing
CDMO competition shifts toward specialist capacity, geography and selective outsourcing
The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 8.7% by 2036
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 9.0% by 2036
Moderna’s flu approval tests whether mRNA can deliver commercial scale
Drug delivery is reshaping biologics development, manufacturing, access and competition
Ageing reshapes pharma portfolios as access, evidence and delivery determine growth
The global Active Pharmaceutical Ingredients (APIs) market is Projected to grow at a CAGR of 6.6% by 2036
Policy, platforms and manufacturing are reshaping global vaccine market opportunities
Manufacturing readiness now determines which cell and gene therapies scale
Precision medicine shifts value from therapies to diagnostics, evidence and access
The global cell & gene therapy manufacturing market is valued at US$13.7 billion in 2026
Healthcare moves home as pharma’s commercial model shifts toward patients
Patient persistence is becoming pharma’s next growth test after launch
Prevention-led pharma growth depends on earlier intervention, access and scale
Healthcare growth is shifting from standard treatments to personalised patient strategies
Women’s health trials enter a more evidence-led, higher-value growth phase
The global Women’s Clinical Trials & CROs Market is projected to grow at a CAGR of 8.5% by 2036
Vaccines are shifting from prevention into platforms, oncology and manufacturing-led growth
The global Vaccine Sales market is projected to grow at a CAGR of 6.3% by 2036
Pre-filled syringes shift from convenience to strategic biologics delivery platform